What does VISION HEALTHCARE do?

VISION HEALTHCARE is registered with the CBE as active in: Vervaardiging van geneesmiddelen. Public Limited, started on 12 December 2017, 1 establishment.

What is the address of VISION HEALTHCARE?

The registered office of VISION HEALTHCARE is located at Nijverheidslaan 3, 8560 Wevelgem.

Is VISION HEALTHCARE still active?

Yes. According to the CBE (29 October 2026) VISION HEALTHCARE is active, legal situation “Normale toestand”, started on 12 December 2017.

Is VISION HEALTHCARE registered on Peppol?

Yes, VISION HEALTHCARE is registered on the Peppol network with ID 0208:0685849188.

What is the enterprise number of VISION HEALTHCARE?

The enterprise number of VISION HEALTHCARE is BE0685849188.

When was VISION HEALTHCARE founded?

VISION HEALTHCARE was founded on 12 December 2017.

Who are the directors of VISION HEALTHCARE?

According to the 2025 annual accounts, the directors of VISION HEALTHCARE are: Citini BV, Brandracer BV.

Is VISION HEALTHCARE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 December 2017; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did VISION HEALTHCARE make in 2025?

VISION HEALTHCARE posted a profit after taxes of € 11,577,123 in financial year 2025.

What is the revenue of VISION HEALTHCARE?

In its most recent annual accounts (2025), VISION HEALTHCARE reported revenue of € 14,336,377.

VISION HEALTHCARE (Public Limited) - Wevelgem

Dossier VISION HEALTHCARE, printed on 29 October 2026 from databakkes.be/en/0685849188/vision-healthcare. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

VISION HEALTHCARE from Wevelgem, company number BE0685849188, closed financial year 2025 with a result of € 11.6 million after tax. For that financial year VISION HEALTHCARE recorded revenue of € 14.3 million and equity of € 153.7 million. Compared with financial year 2024, the result moved from € -5.9 million to € 11.6 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.

What it is worth Growing

€ 153.7 million

▲ 25% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 11.6 million

▲ still € 5.9 million loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 8

▼ 91% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -9.1 million.

Debts at end 2025

Bank debt

€ 123 million

▼ 4% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 760,903

▼ 26% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 16 days on average.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 11,244,553 Revenue 2022: € 11,244,553 First fiscal year in the series	€ 11,432,864 Revenue 2023: € 11,432,864 ▲ 2% vs 2022 (€ 11,244,553) Favourable step	€ 11,987,160 Revenue 2024: € 11,987,160 ▲ 5% vs 2023 (€ 11,432,864) Favourable step	€ 14,336,377 Revenue 2025: € 14,336,377 ▲ 20% vs 2024 (€ 11,987,160) Favourable step	▲ 20%
Profit after taxes	€ 1,425,699 Profit after taxes 2022: € 1,425,699 First fiscal year in the series	€ -1,988,462 Profit after taxes 2023: € -1,988,462 ▼ € 3.4 million vs 2022 (€ 1,425,699) Unfavourable step	€ -5,921,479 Profit after taxes 2024: € -5,921,479 ▼ € 3.9 million vs 2023 (€ -1,988,462) Unfavourable step	€ 11,577,123 Profit after taxes 2025: € 11,577,123 ▲ € 17.5 million vs 2024 (€ -5,921,479) Favourable step	▲ € 17.5 million
Equity	€ 130,465,947 Equity 2022: € 130,465,947 First fiscal year in the series	€ 128,477,485 Equity 2023: € 128,477,485 ▼ 2% vs 2022 (€ 130,465,947) Unfavourable step	€ 122,556,007 Equity 2024: € 122,556,007 ▼ 5% vs 2023 (€ 128,477,485) Unfavourable step	€ 153,669,413 Equity 2025: € 153,669,413 ▲ 25% vs 2024 (€ 122,556,007) Favourable step	▲ 25%
Total debts	€ 144,356,608 Total debts 2022: € 144,356,608 First fiscal year in the series	€ 141,831,006 Total debts 2023: € 141,831,006 ▼ 2% vs 2022 (€ 144,356,608) Favourable step	€ 131,302,878 Total debts 2024: € 131,302,878 ▼ 7% vs 2023 (€ 141,831,006) Favourable step	€ 130,175,709 Total debts 2025: € 130,175,709 ▼ 1% vs 2024 (€ 131,302,878) Favourable step	▼ 1%
Cash	€ 8,011,651 Cash 2022: € 8,011,651 First fiscal year in the series	€ 6,405,508 Cash 2023: € 6,405,508 ▼ 20% vs 2022 (€ 8,011,651) Unfavourable step	€ 91 Cash 2024: € 91 ▼ € 6.4 million vs 2023 (€ 6,405,508) Unfavourable step	€ 8 Cash 2025: € 8 ▼ 91% vs 2024 (€ 91) Unfavourable step	▼ 91%
Retained profit	€ -12,811,499 Retained profit 2022: € -12,811,499 First fiscal year in the series	€ -14,799,961 Retained profit 2023: € -14,799,961 ▼ € 2 million vs 2022 (€ -12,811,499) Unfavourable step	€ -20,721,439 Retained profit 2024: € -20,721,439 ▼ € 5.9 million vs 2023 (€ -14,799,961) Unfavourable step	€ -9,144,316 Retained profit 2025: € -9,144,316 ▲ € 11.6 million vs 2024 (€ -20,721,439) Favourable step	▲ € 11.6 million
Bank debt	€ 141,399,669 Bank debt 2022: € 141,399,669 First fiscal year in the series	€ 136,946,055 Bank debt 2023: € 136,946,055 ▼ 3% vs 2022 (€ 141,399,669) Favourable step	€ 128,411,518 Bank debt 2024: € 128,411,518 ▼ 6% vs 2023 (€ 136,946,055) Favourable step	€ 123,004,060 Bank debt 2025: € 123,004,060 ▼ 4% vs 2024 (€ 128,411,518) Favourable step	▼ 4%
Balance sheet total	€ 274,822,555 Balance sheet total 2022: € 274,822,555 First fiscal year in the series	€ 270,308,491 Balance sheet total 2023: € 270,308,491 ▼ 2% vs 2022 (€ 274,822,555) Unchanged	€ 253,858,884 Balance sheet total 2024: € 253,858,884 ▼ 6% vs 2023 (€ 270,308,491) Unchanged	€ 283,845,122 Balance sheet total 2025: € 283,845,122 ▲ 12% vs 2024 (€ 253,858,884) Unchanged	▲ 12%

Key figures of VISION HEALTHCARE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to VISION HEALTHCARE?

What happened at VISION HEALTHCARE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 Citini BV stepped down as director. NBB
2028 Brandracer BV stepped down as director. NBB
Jun 22, 2026 New annual accounts for financial year 2025: profit of € 11.6 million. Source: NBB ↗
2024 Citini BV became a director. NBB
2021 Brandracer BV became a director. NBB
Jan 1, 2018 New establishment in Wevelgem. KBO
Dec 12, 2017 Start of the company according to the CBE. KBO

In short

From € 1.4 million profit in 2022 to € 11.6 million profit in 2025.

Paid € 83,870 in corporate taxes since 2022.

Best year ever: 2025, with € 11.6 million profit.

Pays suppliers within 16 days on average.

Original PDFs at the National Bank ↗

Management

Vision Consumer Health 100%

QUAEROQ 10.2%

The stake of Vision Consumer Health, QUAEROQ comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

VISION HEALTHCARE

Purasana 100%

Bärbel Drexel GmbH 100%

Remark BV 100%

AixSwiss BV 100%

The shares are held by Vision Consumer Health (100%) and QUAEROQ (10.2%). It owns 100% of Purasana, 100% of Bärbel Drexel GmbH, 100% of Remark BV, 100% of AixSwiss BV, 100% of Flinndal BV and 100% of Vision Healthcare BV itself.

Directors

According to the 2025 annual accounts

Citini BV

Director · represented by Matthias Deconinck

Also active at: Vision CHC, Vision Consumer Health

since 2024 · until 2030

Brandracer BV

Director · represented by Geert Cools

Also active at: Vision CHC, Vision Consumer Health, Republic of Inspiring Brands

since 2021 · until 2028

Shareholders

Vision Consumer Health

100%

QUAEROQ

10.2%

Participations

Purasana

100%

Bärbel Drexel GmbH

100%

Remark BV

100%

AixSwiss BV

100%

Flinndal BV

100%

Vision Healthcare BV

100%

Vision Healthcare Nordic AB

100%

New Care Supplements BV

100%

Nordic Nutriment ApS

100%

Establishments

Establishment units

Physical locations of this company

Registered office

Nijverheidslaan 3

8560 Wevelgem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

PURASANA same network

€ 16 million revenue · 2025

ALPHA FOODS

€ 21.6 million revenue · 2024

Vision HC

€ 6.8 million revenue · 2025

Vision CHC same network

Vision Consumer Health same network

€ 4.5 million revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0685.849.188

VAT number

BE 0685.849.188

Registered office

Nijverheidslaan 3, 8560 Wevelgem

Names & denominations

VISION HEALTHCARE

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

12 December 2017

Peppol

Active · Active since 20 Nov 2020

Activities · NACE

Vervaardiging van geneesmiddelen

Activiteiten van holdings

Vervaardiging van overige farmaceutische producten

Groothandel in farmaceutische en medische artikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

VISION HEALTHCARE

Financials

What happened to VISION HEALTHCARE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions